Author:
The link below connects to a new paper which reviews a novel hypoxia marker – HypoxiTRAK™ – a homogeneous live-cell permeant reagent which provides a dynamic readout of longitudinal hypoxia levels in live MCTS cultures that is compatible with HCS detection, analysis, and throughput.
HypoxiTRAK™ is manufactured by BioStatus Limited – the founding company of OncoTherics.
OncoTherics is currently raising first round funding. If you are interested in taking part, please provide your contact details so that we can include you on our contact list.
Are you working on a project where OncoTherics' technology might be of help or would you like to collaborate in our research? Please provide your contact details so that we can include you on our contact list.